Cashu | QURE | News

HomeWatchlistNewsSignalsPicks

DJI

-0.44%

SPX

-0.28%

IXIC

-0.28%

FTSE

+0.42%

N225

-3.38%

AXJO

-0.82%

⌘K

HomeWatchlistNewsSignals

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Stocks

Health Care

qure

uniQure N.V.

NASDAQ: QURE

+0.55 (+3.73%)

15.28

USD

At close at Mar 19, 20:40 UTC

Join our newsletter to keep up to date with us!

Latest uniQure N.V. News

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm

Feature Image for interests on Banking & Financial Services, Healthcare, Stock from prnewswire.com

uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

about 2 hours ago

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure Lawsuit - QURE

Feature Image for interests on Healthcare, Stock from prnewswire.com

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit

Feature Image for interests on Banking & Financial Services, Healthcare, Stock from prnewswire.com

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Feature Image for interests on Broadcast Feed Annoucement, Healthcare, Stock from prnewswire.com

uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face April 13, 2026, Deadline

Feature Image for interests on Healthcare, Stock from prnewswire.com

uniQure N.V. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 13, 2026 to Discuss Your Rights - QURE

Feature Image for interests on Healthcare, Stock from prnewswire.com

uniQure Shares Surge 26% On US FDA Shakeup Even As Momentum Tumbles: Will New Leadership Greenlight Huntington's Therapy?

Feature Image for interests on Analyst Color, Benzinga Ratings, Equities, Financial Services from benzinga.com

What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?

Feature Image for interests on Analyst Color, Expert Ideas, Healthcare, Stock from benzinga.com

What the Options Market Tells Us About uniQure

Feature Image for interests on Bzi-Uoa, Healthcare, Markets, Options from benzinga.com

Latest Cashu News

uniQure N.V. Faces Class Action Lawsuits Over Alleged Investor Misleading Communications

uniQure N.V. Faces Class Action Lawsuit Over Huntington's Disease Drug Misrepresentations

Class Action Against uniQure N.V. Over Alleged Drug Approval Misrepresentation